1.The Effect of Koryo-Hand-Acupuncture on Recurrent Abdominal Pain of Children.
Korean Journal of Child Health Nursing 2001;7(4):519-529
Recurrent abdominal pain(RAP) occurs in 8-10% of elementary school children. It is suspected that functional causes are about 90% and organic causes about 10% for the recurrent abdominal pain. RAP is treated by antispasmodics or analgesics or antidiarrheal drugs in school health rooms. The purpose of this study was to verify the effect of Koryo-Hand-Acupuncture on recurrent abdominal pain of children. The duration of this study was from April to July, 2001. The subjects were the grade 4th-6th elementary students complaining recurrent abdominal pain. Total subjects were 46 cases; 23 cases of which were placed in experimental and the others in control group. The results of this study were as follows; 1.Numeric-pain-intensity of experimental group received Koryo-Hand-Acupuncture was decreased more than that of control group received mock Koryo-Hand-Acupuncture significantly. 2.Probed current in stomach corresponding point (A12) of experimental received Koryo-Hand-Acupuncture was decreased more than that of control group received mock Koryo-Hand-Acupuncture significantly. 3.Medication requirement rate of experimental group received Koryo-Hand-Acupuncture was decreased more than that of control group received mock Koryo-Hand-Acupuncture significantly. The following suggestions with the results of the study would be made like these; 1.Stimulation implement of Koryo-Hand- Acupuncture should be used independently and each effect should be investigated. 2. With repeated studies for various signs and diseases, the effect of Koryo-Hand- Acupuncture must be verified.
Abdominal Pain*
;
Acupuncture
;
Analgesics
;
Antidiarrheals
;
Child*
;
Humans
;
Parasympatholytics
;
School Health Services
;
Stomach
;
Child Health
2.The Effect of Koryo-Hand-Acupuncture on Recurrent Abdominal Pain of Children.
Korean Journal of Child Health Nursing 2001;7(4):519-529
Recurrent abdominal pain(RAP) occurs in 8-10% of elementary school children. It is suspected that functional causes are about 90% and organic causes about 10% for the recurrent abdominal pain. RAP is treated by antispasmodics or analgesics or antidiarrheal drugs in school health rooms. The purpose of this study was to verify the effect of Koryo-Hand-Acupuncture on recurrent abdominal pain of children. The duration of this study was from April to July, 2001. The subjects were the grade 4th-6th elementary students complaining recurrent abdominal pain. Total subjects were 46 cases; 23 cases of which were placed in experimental and the others in control group. The results of this study were as follows; 1.Numeric-pain-intensity of experimental group received Koryo-Hand-Acupuncture was decreased more than that of control group received mock Koryo-Hand-Acupuncture significantly. 2.Probed current in stomach corresponding point (A12) of experimental received Koryo-Hand-Acupuncture was decreased more than that of control group received mock Koryo-Hand-Acupuncture significantly. 3.Medication requirement rate of experimental group received Koryo-Hand-Acupuncture was decreased more than that of control group received mock Koryo-Hand-Acupuncture significantly. The following suggestions with the results of the study would be made like these; 1.Stimulation implement of Koryo-Hand- Acupuncture should be used independently and each effect should be investigated. 2. With repeated studies for various signs and diseases, the effect of Koryo-Hand- Acupuncture must be verified.
Abdominal Pain*
;
Acupuncture
;
Analgesics
;
Antidiarrheals
;
Child*
;
Humans
;
Parasympatholytics
;
School Health Services
;
Stomach
;
Child Health
3.The Therapeutic Effect of Lactobacillus reuteri in Acute Diarrhea in Infants and Toddlers.
Tae Hun EOM ; Eun Young OH ; Young Hoon KIM ; Hyun Seung LEE ; Pil Sang JANG ; Dong Un KIM ; Jin Tack KIM ; Byung Churl LEE
Korean Journal of Pediatrics 2005;48(9):986-990
PURPOSE: Certain strains of lactobacilli are known to accelerate recovery from acute diarrhea. Lactobacillus reuteri is isolated from human breast milk and a commonly occurring Lactobacillus species with therapeutic potential in acute diarrhea. The purpose of the present study was to investigate the therapeutic effect of L. reuteri in acute diarrhea in young children. METHODS: Fifty patients between 6 and 36 months of age hospitalized with acute diarrhea (rotavirus in 40 percent) were randomized into two groups to receive either 10 (8) colony-forming units of L. reuteri or a matching placebo, twice a day for their length of hospitalization, or for up to 5 days. Antidiarrheal drugs were not prescribed to either group. The clinical outcome of diarrhea was evaluated. RESULTS: The mean duration of watery diarrhea after initiation of treatment was 2.3 days for the L. leuteri group (n=25) vs. 2.9 days for the placebo group (n=25) (P=0.072). By the second day of treatment, watery diarrhea persisted in 64 percent of patients receiving L. reuteri, compared to 84 percent of those receiving placebo (P=0.006). On the second day, the mean frequency of watery diarrhea was 1.9 in the L. leuteri group and 3.4 in the placebo (P=0.046). Also, vomiting continued to the second day in 16 percent of patients receiving L. reuteri and 40 percent of those recieving placebo (P= 0.031). CONCLUSION: L. reuteri is effective as a therapeutic agent in acute diarrhea in children.
Antidiarrheals
;
Child
;
Diarrhea*
;
Hospitalization
;
Humans
;
Infant*
;
Lactobacillus reuteri*
;
Lactobacillus*
;
Milk, Human
;
Stem Cells
;
Vomiting
4.Determining the protective effects of Ma-Mu-Ran Antidiarrheal Capsules against acute DSS-induced enteritis using 16S rRNA gene sequencing and fecal metabolomics.
Si-Li ZHENG ; Dong-Ning ZHANG ; Yan-Fen DUAN ; Fang HUANG ; Lin-Tao HAN ; Guo-Yan MO
Chinese Journal of Natural Medicines (English Ed.) 2022;20(5):364-377
Ma-Mu-Ran Antidiarrheal Capsules (MMRAC) is traditional Chinese medicine that has been used to treat diarrhea caused by acute enteritis (AE) and bacillary dysentery in Xinjiang (China) for many years. However, the potential therapeutic mechanism of MMRAC for AE and its regulatory mechanism on host metabolism is unclear. This study used fecal metabolomics profiling with GC/MS and 16S rRNA gene sequencing analysis to explore the potential regulatory mechanisms of MMRAC on a dextran sulfate sodium salt (DSS)-induced mouse model of AE. Fecal metabolomics-based analyses were performed to detect the differentially expressed metabolites and metabolic pathways. The 16S rRNA gene sequencing analysis was used to assess the altered gut microbes at the genus level and for functional prediction. Moreover, Pearson correlation analysis was used to integrate differentially expressed metabolites and altered bacterial genera. The results revealed that six intestinal bacteria and seven metabolites mediated metabolic disorders (i.e., metabolism of amino acid, carbohydrate, cofactors and vitamins, and lipid) in AE mice. Besides, ten altered microbes mediated the differential expression of eight metabolites and regulated these metabolisms after MMRAC administration. Overall, these findings demonstrate that AE is associated with metabolic disorders and microbial dysbiosis. Further, we present that MMRAC exerts protective effects against AE by improving host metabolism through the intestinal flora.
Animals
;
Antidiarrheals/pharmacology*
;
Capsules
;
Enteritis/genetics*
;
Feces/microbiology*
;
Genes, rRNA
;
Metabolomics
;
Mice
;
RNA, Ribosomal, 16S/genetics*
5.Influence of length of preserved ileocecum on the efficacy of laparoscopic subtotal colectomy antiperistaltic cecorectal anastomosis in the treatment of slow transit constipation.
Dong WEI ; Jian CAI ; Ting ZHAO ; Hui ZHANG ; Yuanyao ZHANG ; Jianfeng ZHANG ; Yongli CAO
Chinese Journal of Gastrointestinal Surgery 2015;18(5):454-458
OBJECTIVETo investigate the influence of length of preserved ileocecum on the efficacy of laparoscopic subtotal colectomy antiperistaltic cecorectal anastomosis (LSCACRA) in treating slow transit constipation (STC).
METHODSClinical data of 81 STC patients who received LSCACRA between April 2007 And December 2011 in the 150th Center Hospital of PLA were continuously collected. Patients were divided into two groups: 10 cm to 15 cm ascending colon preserved above ileocecal junction(10-15 cm group, n=41), and 2 cm to 3 cm ascending colon preserved above ileocecal junction (2-3 cm group, n=40). The Wexner constipation scale (WCS), Wexner incontinence scale(WIS), gastrointestinal quality of life index(GIQLI), abdominal pain intensity scale(NRS), abdominal pain frequency scale and abdominal bloating frequency scale in the two groups were determined and compared before and 6, 12, 24 months after operation.
RESULTSNo postoperative incontinence was found in all the patients. There were no significant differences in evacuation frequency between two groups at 6th and 12th month after surgery (all P>0.05). Two years after operation, barium enema emptying time examination revealed 2-3 cm group was (17.7±9.5) h, which was remarkably shorter than (21.2±20.7) h in 10-15 cm group (P=0.011). The WCS, GIQLI, NRS and abdominal pain frequency scale of two groups were improved obviously at 6th, 12th and 24th month after surgery (all P<0.01). Above parameters in 2-3 cm group were superior to 10-15 cm group (all P<0.01), but abdominal bloating frequency scale was not significantly different between the two groups (P>0.05). As compared with before operation, NRS in 2-3 cm group 6, 12, 24 months after operation reduced remarkably (all P<0.01), but did not improve obviously in 10-15 cm group (P>0.05).
CONCLUSIONThe shorter length of ascending colon preserved above ileocecal junction can improve the efficacy of LSCACRA in the treatment of STC and the prognosis of patients. Two to three cm length of ascending colon preserved above the ileocecal junction should be recommended.
Abdominal Pain ; Anastomosis, Surgical ; Antidiarrheals ; Cecum ; Colectomy ; Constipation ; Enema ; Humans ; Ileum ; Laparoscopy ; Postoperative Period ; Prognosis ; Quality of Life ; Rectum ; Treatment Outcome
6.Treatment of fecal incontinence.
Journal of the Korean Medical Association 2012;55(1):31-36
Fecal incontinence is defined as either the involuntary passage of gas or stool or the inability to control the passage of fecal contents through the anus. Patients are reluctant to report fecal incontinence, resulting in underestimated prevalence. Studies have reported that its prevalence ranges from 2% to 20%. Diverse causes are involved in the generation of fecal incontinence. Fecal incontinence leads to a loss of self-esteem, social isolation, and a diminished quality of life. Antidiarrheals are useful for diarrhea with incontinence. Biofeedback therapy and exercise therapies may be helpful, particularly in patients with weak sphincters and/or impaired rectal sensation. Sacral nerve stimulation can be an option if other treatments have not been successful. Although some studies have shown the efficacy of injectable bulking agents, data on their long-term outcome and experience are lacking. Sphincteroplasty can be considered in selected patients who have failed nonsurgical measures or biofeedback therapy. A colostomy is a less preferable option. The various treatment options can be chosen with an individualized approach, depending on the causes of fecal incontinence, the action mechanism of treatment, comorbidities, general condition, and procedure-related risks.
Anal Canal
;
Antidiarrheals
;
Biofeedback, Psychology
;
Colostomy
;
Comorbidity
;
Diarrhea
;
Exercise Therapy
;
Fecal Incontinence
;
Humans
;
Prevalence
;
Quality of Life
;
Sensation
;
Social Isolation
7.Pharmacological evaluation of Musa seminifera Lour. fruit.
Sanjib SAHA ; E-mail: SANJIBSAHA1991@YAHOO.COM. ; Faroque HOSSAIN ; Md ANISUZZMAN ; Md Khirul ISLAM
Journal of Integrative Medicine 2013;11(4):253-261
OBJECTIVETo study potential antioxidant, analgesic, antidiarrheal, and antibacterial activities of the ethanol extract of Musa seminifera Lour. fruit in different established in vivo and in vitro experimental models.
METHODSIn vitro antioxidant activity was studied in 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical-scavenging assay. Phenolic content was determined using Folin-Ciocalteu's reagent. Reducing ability was evaluated by ferric reducing power assay. Peripherally and centrally acting analgesic activity was studied in three different in vivo models, namely, acetic acid-induced writhing, hot-plate test, and tail-flick test in Swiss albino mice. In vivo antidiarrheal activity was evaluated in castor oil- and magnesium sulfate-induced diarrhea in mice. Gastrointestinal motility test was also carried out in mice. All studies in mice were undertaken at the doses of 250 and 500 mg/kg body weight. Antibacterial activity was assessed by disk diffusion assay against some Gram-positive and Gram-negative bacterial strains. Acute toxicity test was conducted to assess the safe doses of the extract.
RESULTSThe extract showed 50% inhibitory concentration value of 12.65 μg/mL in DPPH radical-scavenging assay. Phenolic content was found to be 589.83 mg gallic acid equivalent per 100 g of dried fruits extract. Reducing power was in a concentration-dependent manner, and strongly comparable with the standard ascorbic acid. The extract demonstrated significant inhibition of writhing in acetic acid-induced writhing test at both dose levels (P<0.01). The extract also raised pain threshold in both hot-plate and tail-flick test in a dose-dependent manner, and the results were statistically significant (P<0.01). The extract significantly (P<0.01) increased latent period, and decreased defecation in both castor oil- and magnesium sulfate-induced diarrhea. The extract also decreased gastrointestinal motility in mice. In disk diffusion assay, the extract showed potential antibacterial activity against all the tested bacterial strains.
CONCLUSIONThe results suggest that the ethanol extract of M. seminifera fruit has potential antioxidant, analgesic, antidiarrheal, and antibacterial activities.
Analgesics ; pharmacology ; Animals ; Anti-Bacterial Agents ; pharmacology ; Antidiarrheals ; pharmacology ; Antioxidants ; pharmacology ; Female ; Fruit ; Male ; Mice ; Musa ; Plant Extracts ; pharmacology ; toxicity
8.A Case of Intractable Diarrhea Associated with Early Onset Secondary Amyloidosis in Rheumatoid Arthritis.
Sung Min NOH ; Chae Kyu KIM ; Yong Ho SONG ; Ja Hun JUNG ; Hyun Kyu CHANG ; Tae Hwan KIM ; Jae Bum JUN ; Sung Soo JUNG ; In Hong LEE ; Sang Cheol BAE ; Dae Hyun YOO ; Seong Yoon KIM
The Journal of the Korean Rheumatism Association 1999;6(3):247-252
Amyloidosis is a disease that characterized by accumulation of an amorphous, proteinaceous materials in the various tissues and organs, but its origin is unknown. Recent clinical study showed that incidence of amyloidosis in rheumatoid arthritis was near 10% to 21%. Secondary amyloidosis is caused by accumulation of serum amyloid. A which is doing the acute phase behavior faster than C reactive protein. Symptoms of amyloidosis are various according to the involved organ. Gastrointestinal symptoms are obstruction, ulcer, malabsorption, and bleeding. Diarrhea is very intractable with the conventional antidiarrheal agent, the mechanism of that is infiltration of amyloid material in the intestinal myenteric plexus, sympathetic nerve and ganglion. We report a case of 65 years old woman with rheumatoid arthritis presented with abdominal pain, intractable diarrhea which was not controlled by antidiarrheal agents. Duration of arthritis is only 2 years. Immunohistochemical stain showed AA type which meant secondary form. We treated with Octreotide analogue and total parenteral nutrition for chronic diarrhea.
Abdominal Pain
;
Aged
;
Amyloid
;
Amyloidosis*
;
Antidiarrheals
;
Arthritis
;
Arthritis, Rheumatoid*
;
C-Reactive Protein
;
Diarrhea*
;
Female
;
Ganglion Cysts
;
Hemorrhage
;
Humans
;
Incidence
;
Myenteric Plexus
;
Octreotide
;
Parenteral Nutrition, Total
;
Ulcer
9.Drug Therapy of Irritable Bowel Syndrome.
Journal of the Korean Medical Association 2002;45(5):629-637
Irritable bowel syndrome (IBS) is a chronic relapsing disorder of gastrointestinal function, the main features of which are abdominal pain or discomfort and an alteration of the bowel habit. Rome Ⅱ criteria is the most recent international consensus definition for IBS. Rome Ⅱ consensus provides working definitions for constipation-(C-IBS) and diarrhea-predominant (D-IBS) subgroups. Initial management begins with a detailed history taking, including a careful dietary history. The presence of obvious causative factors of stress should be identified. Therapeutic trials may include those of dietary fiber supplementation for C-IBS, dietary manipulation and/or antidiarrheal agents for D-IBS, and antispasmodics for prominent pain. Reassurance of the patient is vital in the initial management. Current approaches to the long-term management of IBS include dietary measures, fiber and bulking agents, antispasmodic agents, antidiarrheal agents, laxatives, psychotroic drugs, and psychological and behavioral therapy. Medications should be prescribed as required, rather than on a regular basis. For moderate or severe abdominal pain, antispasmodics and certain smooth muscle relaxants may be used. These types of drugs are ideally used for a short term during an exacerbation of symptoms. In resistant cases, low-dose antidepressants have been used to treat the abdominal pain of IBS. For diarrhea, loperamide can be used effectively on a p.r.n. basis. For constipation, an increase in dietary fiber and/or dietary fiber supplements should be continued in a long-term basis. If symptoms continue, osmotic laxatives can be tried. Anthraquinone laxatives such as aloe or senna should be avoided in long-term treatment.
Abdominal Pain
;
Aloe
;
Antidepressive Agents
;
Antidiarrheals
;
Consensus
;
Constipation
;
Diarrhea
;
Dietary Fiber
;
Drug Therapy*
;
Humans
;
Irritable Bowel Syndrome*
;
Laxatives
;
Loperamide
;
Muscle, Smooth
;
Parasympatholytics
10.Microscopic colitis in a single center study: clinical feature & characteristics.
Se Young LEE ; Seong Woo JEON ; Yun Jin CHUNG ; Young Dae PARK ; Seok Jin YOON ; Soo Young PARK ; Eun Su KIM ; Min Kyu JUNG ; Sung Kook KIM ; Yong Hwan CHOI ; Chang Min CHO ; Won Young TAK ; Young Oh KWEON
Korean Journal of Medicine 2008;74(4):397-402
BACKGROUND/AIMS: Collagenous colitis (CC) and lymphocytic colitis (LC) are characterized by chronic diarrhea and normal radiologic and endoscopic findings. These are currently not uncommon entities whose incidence in increasing as more clinicians take biopsies from macroscopically normal colons. The purpose of this study was to examine the clinical features and characteristics in microscopic colitis. METHODS: From January 2003 to December 2006, medical records were reviewed from 80 patients with chronic diarrhea, who had normal colonoscopic findings but underwent biopsy. Patients with microscopic colitis were identified by reviewing the pathology databases and by reviewing biopsies. RESULTS: Microscopic colitis was diagnosed in 12 patients (15%). Six patients with CC (Male:Female=2:4, mean age 54+/-20.1 years) and 6 patients with LC (Male:Female=5:1, mean age 51.2+/-21.4 years) were identified. Autoimmune disease was diagnosed in 4 patients (33%). Drug-induced disease was suspected in 3 patients (25%). The inciting drugs were NSAIDs, ticlopidine, ranitidine, and acarbose. Complete or partial resolution of diarrhea was achieved in all patients, including spontaneous resolution in 2 patients. Antidiarrheal drugs, mesalazine, and cholestylamine were highly effective in both diseases. Recurrence of symptoms occurred in 2 patients (17%). They are taking medicine at present. CONCLUSIONS: Microscopic colitis is a relatively common cause of chronic diarrhea that appears to be increasing in incidence. We reported clinical features, characteristics, treatment, and response of microscopic colitis in our experience.
Acarbose
;
Anti-Inflammatory Agents, Non-Steroidal
;
Antidiarrheals
;
Autoimmune Diseases
;
Biopsy
;
Colitis, Collagenous
;
Colitis, Lymphocytic
;
Colitis, Microscopic
;
Colon
;
Diarrhea
;
Humans
;
Incidence
;
Medical Records
;
Mesalamine
;
Ranitidine
;
Recurrence
;
Ticlopidine